RMRemika Mito

Remika Mito

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Remika Mito has a total of 133 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Wavelet-Fusion Diffusion Model for Multimodal Brain MRI Synthesis with Modality and Metadata Conditioning

    by Muhammad Nabi Yasinzai, Remika Mito, Mangor Pedersen

    Multimodal MRI provides complementary information for neuroimaging analysis, with different modalities capturing distinct anatomical, tissue, and pathological features relevant to downstream artificial intelligence (AI) applications. Although large-scale structural MRI resources are increasingly available, modality coverage remains uneven across public and pooled neuroimaging datasets. Large pooled datasets span heterogeneous sites, scanners, and acquisition protocols and often contain incomplete or inconsistent demographic and clinical metadata. Synthetic MRI can supplement missing or underrepresented modalities and support metadata-conditioned synthetic cohorts. However, many existing approaches use limited modality combinations or relatively homogeneous datasets, limiting their applicability to heterogeneous pooled neuroimaging data. Diffusion models can generate high-fidelity, diverse MRI, but direct 3D voxel-space sampling is computationally expensive. Latent diffusion reduces this cost by generating in a compressed space, although information loss during compression can limit synthesis fidelity. We develop the Wavelet-Fusion Diffusion Model (WFDM), a 3D latent diffusion framework for multimodal brain MRI synthesis with target-modality and metadata conditioning. WFDM combines a Wavelet-Fusion variational autoencoder (WF-VAE) compressor with a conditional 3D U-Net diffusion model trained in the latent space. Training and evaluation use 45,880 preprocessed T1w, T2w, T1Gd, and FLAIR scans from 157 BrainScape datasets. Compared with the BrainScape-trained MAISI (Medical AI for Synthetic Imaging) baseline, WFDM reduced pooled MedicalNet feature-space Fréchet distance (FID) from 0.00550 to 0.00404 and pooled Maximum Mean Discrepancy (MMD) from 0.1918 to 0.1471 while maintaining comparable sample diversity. WFDM achieved lower FID and MMD for T1w, T2w, and FLAIR, whereas MAISI achieved lower values for T1Gd. Rectified Flow sampling with 50 steps was 12.4–13.4 times faster than 1000-step DDPM sampling while achieving the lowest pooled FID and MMD in the sampler ablation. In T1w MRI, WFDM also more closely preserved age- and sex-associated morphometric patterns, including age-group morphometric separation, regional age–volume associations, and male–female differences. We release BrainMint for brain MRI synthesis workflows and medmetric for standardized evaluation of 3D medical image synthesis models.

  • Open Access

    Longitudinal quantitative streamline tractography: Robust estimation of white matter connectivity differences

    by Philip Pruckner, Remika Mito, David N. Vaughan, Kurt G. Schilling, Victoria L. Morgan, Dario J. Englot, Robert E. Smith

    Longitudinal probing of structural connectivity via diffusion magnetic resonance imaging (dMRI) is experiencing uptake. However, the detection of biological effects is significantly hampered by the limitations of cross-sectional streamline tractography, where even small changes in the dMRI signal can produce drastically different trajectories and, therefore, quantitative parameterisation; if not properly dealt with, such effects will manifest as spurious longitudinal change, which can obscure subtle biological differences. To address this challenge, we here introduce a novel quantitative streamline tractography framework tailored for longitudinal analysis, wherein an individual’s streamline trajectories remain fixed throughout the analysis, allowing only their ascribed density weights to vary between sessions. We present two strategies by which these quantitative streamline weights can be determined, both extensions of the widely adopted SIFT2 method. The performance of this framework is benchmarked against cross-sectional reconstruction with and without SIFT2 optimisation, in both in silico dMRI phantoms with known ground truths and three distinct human in vivo cohorts with clear a priori expectations of biological effects. We demonstrate that the proposed framework drastically reduces methodological imprecisions in synthetic dMRI phantoms and enhances statistical sensitivity and specificity to biological effects in human cohorts, enabling more robust quantification of longitudinal structural connectivity differences.

  • Open Access

    TRAMFIX: TRavelling Across Melbourne for FIXel-based analysis (a reproducibility and reliability study)

    by Remika Mito, Sila Genc, Jocelyn Halim, Joseph Yuan-Mou Yang, Jacques-Donald Tournier, Michael Kean, Chris Kokkinos, Richard McIntyre, Maria A. Di Biase, Robert E. Smith, et al.

    Fixel-based analysis (FBA) has gained substantial interest for its ability to probe fibre-specific changes in the brain’s white matter from diffusion-weighted imaging data. However, the reproducibility and reliability of fixel-based measures across different scanners remains largely unknown. In this work, we present TRAMFIX (TRavelling Across Melbourne for FIXel-based analysis): a multisite dataset of traveling participants (n = 10 healthy adults) scanned across four 3T MRI scanners using a harmonised multi-shell diffusion-weighted imaging (DWI) protocol. DWI data were processed using two pipelines that can be adopted when performing multi-site FBA studies (site-specific vs. pooled processing). We extracted fixel-based measures of fibre density (FD), fibre cross-section (FC), and fibre density and cross-section (FDC) from the harmonized protocol. While the primary goal was to assess reproducibility and reliability of FBA metrics, we additionally computed diffusion tensor imaging (DTI)-based fractional anisotropy (FA) and mean diffusivity (MD) for the purposes of comparison with previous studies. Within-subject coefficients of variation (CVws) and intraclass correlation coefficients (ICC) of FBA and DTI measures were computed at multiple resolutions of computation and analysis: (i) the whole-brain averaged level, (ii) tract-level, and (iii) fixel- or voxel-level. Fixel-based metrics demonstrated high reproducibility and reliability at the whole-brain level (CVws ranging between 0.51% to 1.57% and ICC between 0.782 and 0.994). While reproducibility and reliability remained high for tract-averaged FBA measures (particularly the FC and FDC metrics), some tracts exhibited lower ICC values < 0.8 for the FD measure. When examining fixel-level reliability and reproducibility, clear spatial patterns emerged, with lower ICC across subcortical and cerebellar regions, and higher CVws at the cortical boundaries. FBA metrics demonstrated comparable, if not slightly better, reliability than tensor-based metrics derived from a subset of the same data. Our findings provide support for the reproducibility and reliability of fixel-based measures, highlighting their potential for use in multi-site FBA studies. Future work examining protocol-related differences, as well as appropriate harmonization strategies when pooling data across sites and scanners, will be valuable. To facilitate this, we provide the TRAMFIX dataset as a resource for investigating reproducibility, reliability, and harmonization of fixel-based analysis measures.


  • Open Access

    Longitudinal quantitative streamline tractography: robust estimation of white matter connectivity differences

    by Philip Pruckner, Remika Mito, David N Vaughan, Kurt G Schilling, Victoria L Morgan, Dario J Englot, Robert E Smith

    Longitudinal probing of structural connectivity via diffusion magnetic resonance imaging (dMRI) is experiencing uptake. However, the detection of biological effects is significantly hampered by the limitations of cross-sectional streamline tractography, where even small changes in the dMRI signal can produce drastically different trajectories and therefore quantitative parameterisation; if not properly dealt with, such effects will manifest as spurious longitudinal change, which can obscure subtle biological differences. To overcome this challenge, we here introduce a novel quantitative streamline tractography framework tailored for longitudinal analysis, wherein an individual’s streamline trajectories remain fixed throughout the analysis, allowing only their ascribed density weights to vary between sessions. We present two strategies by which these quantitative streamline weights can be determined, both extensions of the widely adopted SIFT2 method. The performance of this framework is benchmarked against cross-sectional reconstruction with and without SIFT2 optimisation, in both in silico dMRI phantoms with known ground truths and three distinct human in vivo cohorts with clear a priori expectations of biological effects. We demonstrate that the proposed framework drastically reduces methodological imprecisions in synthetic dMRI phantoms and enhances statistical sensitivity and specificity to biological effects in human cohorts, enabling robust longitudinal quantification of structural connectivity.


  • Open Access

    Utility of Harmonisation for Fixel‐Based Metrics in Travelling Subjects and Alzheimer's Disease Data

    by Rui Zou, Koji Kamagata, Remika Mito, Kaito Takabayashi, Christina Andica, Wataru Uchida, Sen Guo, Takafumi Kitagawa, Shohei Fujita, Akiko Uematsu, et al.

    Fixel‐based analysis (FBA) is an advanced diffusion MRI analysis technique that facilitates the evaluation of white matter microstructure within ‘fixels’ (specific fibre populations within a voxel). In recent years, FBA has gained prominence for its ability to better characterise fibre tract‐specific changes than the more conventional diffusion MRI approaches and has shown promise in elucidating the pathophysiology of psychiatric and neurological diseases. However, FBA has been predominantly limited to single‐centre studies, minimising the generalisability of the technique. In this study, the popular ComBat harmonisation technique was adapted for whole‐brain FBA of diffusion MRI data. The study evaluates the effectiveness of ComBat in harmonising FBA metrics of fibre density, fibre cross‐section and the combined metric of fibre density and cross‐section in a large travelling subject dataset ( n = 49, scan = 162). Participants were scanned across multiple centres, using different scanner models and imaging protocols, and FBA metrics were compared under these varying conditions before and after harmonisation. In addition, the impact of ComBat harmonisation on disease‐related findings was evaluated in an independent multi‐centre Alzheimer's disease (AD) dataset, by comparing the same fixel‐based measures in patients with AD ( n = 27) to those in cognitively normal control participants ( n = 29) before and after ComBat harmonisation. We demonstrated that ComBat harmonisation effectively mitigated variability across scanner sites, scanner models, and protocols, in the travelling subject dataset, thus enhancing the comparability of FBA metrics. Notably, ComBat harmonisation improved the detection of AD‐related changes in the fornix, a critical white matter tract associated with cognitive function, and strengthened the correlations between FBA metrics and cognitive scores. These results underscore the potential of ComBat harmonisation in enhancing the reliability of multi‐centre neuroimaging studies, supporting the use of harmonisation techniques for accurate detection of disease‐specific changes in neurodegenerative conditions. The ability to perform ComBat harmonisation within the whole‐brain FBA pipeline may help further this fibre‐specific technique into large‐scale multi‐centre studies.


  • Automated detection of bottom‐of‐sulcus dysplasia on magnetic resonance imaging–positron emission tomography in patients with drug‐resistant focal epilepsy

    by Emma Macdonald‐Laurs, Aaron E. L. Warren, Remika Mito, Sila Genc, Bonnie Alexander, Sarah Barton, Joseph Yuan‐Mou Yang, Peter Francis, Heath R. Pardoe, Graeme Jackson, et al.

    Objective: Bottom‐of‐sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on magnetic resonance imaging (MRI). Automated MRI‐based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically, and few methods incorporate fluorodeoxyglucose positron emission tomography (FDG‐PET) alongside MRI features. We report the development and performance of an automated BOSD detector using combined MRI + PET. Methods: The training set comprised 54 patients with focal epilepsy and BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. Across training and test sets, 81% of patients had normal initial MRIs and most BOSDs were 3 . In the training set, 12 features from T1‐MRI, fluid‐attenuated inversion recovery–MRI, and FDG‐PET were evaluated to determine which features best distinguished dysplastic from normal‐appearing cortex. Using the Multi‐centre Epilepsy Lesion Detection group's machine‐learning detection method with the addition of FDG‐PET, neural network classifiers were then trained and tested on MRI + PET, MRI‐only, and PET‐only features. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were determined. Results: Cortical and subcortical hypometabolism on FDG‐PET was superior in discriminating dysplastic from normal‐appearing cortex compared to MRI features. When the BOSD detector was trained on MRI + PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 94% in the prospective test set (88% top cluster), and 75% in the published test set (58% top cluster). Cluster overlap was generally lower when the detector was trained and tested on PET‐only or MRI‐only features. Significance: Detection of BOSD is possible using established MRI‐based automated detection methods, supplemented with FDG‐PET features and trained on a BOSD‐specific cohort. In clinically appropriate patients with seemingly negative MRI, the detector could suggest MRI regions to scrutinize for possible BOSD.


  • Open Access

    Surgical white matter disruption leads to downstream atrophy in the non-resected human brain

    by Philip Pruckner, Remika Mito, David N Vaughan, Graeme D Jackson, Florian Fischmeister, Karl-Heinz Nenning, Marc Berger, Ekaterina Pataraia, Christoph Baumgartner, Christian Dorfer, et al.

    Resective neurosurgery is a cornerstone treatment for many neurological conditions. Although traditionally viewed as a localized procedure, increasing evidence from advanced MRI shows that non-resected anatomy can degenerate following surgery. The relationship between local tissue removal and these postoperative changes remains speculative. Here, we investigate the hypothesis that degenerative changes to surgically preserved grey and white matter are mediated by transneuronal degeneration, a deterioration of intact neuronal populations due to lost axonal input. Using a robust diffusion-weighted and T1-weighted MRI framework specifically tailored for longitudinal analysis of surgical image data, we evaluated evidence to support this mechanism in a series of patients undergoing resective surgery for epilepsy; namely, anterior temporal lobectomy (ATL, n = 31) or selective amygdalohippocampectomy (SAHE, n = 28). We mapped three key aspects of transneuronal degeneration for anatomical regions: (i) loss of surgically resected white matter; (ii) longitudinal change in cortical thickness; and (iii) longitudinal atrophy of non-resected white matter. Using mixed-effects models, we explored the evidence in support of a sequential progression of degeneration, where the loss of resected white matter leads to downstream atrophy of connected grey matter and the white matter connections thereof. Both ATL and SAHE resulted in extensive resection-related white matter losses predominantly connecting to ipsilateral regions close to the resection. We also found pronounced decreases in cortical thickness in these regions, as well as extensive white matter atrophy across the ipsilateral hemisphere. These postsurgical alterations were closely associated with resection-related white matter losses, with every 10-fold loss of connections leading to a 3.4% decrease in cortical thickness and a 7.2% decrease in density of downstream pathways. Beyond degenerative effects, we also demonstrate how failure to properly tailor longitudinal image processing to such data can yield misleading evidence for extensive structural network reorganization, with our more robust approach indicating limited capacity for macroscale plasticity post-resection.


  • Open Access

    TRAMFIX: TRavelling Across Melbourne for FIXel-based analysis (a reproducibility study)

    by Remika Mito, Sila Genc, Jocelyn Halim, Joseph Yuan-Mou Yang, Jacques-Donald Tournier, Michael Kean, Chris Kokkinos, Richard McIntyre, Maria A. Di Biase, Robert Smith, et al.

    Fixel-based analysis (FBA) has gained substantial interest for its ability to probe fibre-specific changes in the brain’s white matter from diffusion-weighted imaging data. However, the reproducibility and reliability of fixel-based measures across different scanners remains largely unknown. In this work, we present TRAMFIX: a multisite dataset of travelling participants (n=10 healthy adults) scanned across four 3T MRI scanners using a harmonised multi-shell DWI protocol. DWI data were processed using two pipelines that can adopted when performing multi-site FBA studies (site-specific versus pooled processing). We extracted fixel-based measures of fibre density (FD), fibre cross-section (FC), and fibre density and cross-section (FDC), as well as diffusion tensor imaging (DTI)-based fractional anisotropy (FA) and mean diffusivity (MD) from the harmonised protocol. Within-subject coefficients of variation (CV ws ) and intraclass correlation coefficients (ICC) of FBA and DTI measures were computed at multiple resolutions of computation and analysis: (i) the whole-brain averaged level, (ii) tract-level, and (iii) fixel- or voxel-level. Fixel-based metrics demonstrated high reproducibility and reliability at the whole-brain level (CV ws ranging between 0.51% to 1.57% and ICC between 0.93 and 0.996). While reproducibility and reliability remained high for tract-averaged FBA measures (particularly the FC and FDC metrics), some tracts exhibited lower ICC values < 0.8 for the FD measure. When examining fixel-level reliability and reproducibility clear spatial patterns emerged, with lower ICC across subcortical and cerebellar regions, and higher CV ws at the cortical boundaries. Across all levels, tensor-based metrics demonstrated slightly lower reproducibility and reliability metrics than FBA measures, suggesting that FBA metrics are just as, if not more, reproducible than DTI metrics across scanners when using identical protocols. Our findings provide support for the reproducibility and reliability of fixel-based measures, highlighting their potential for use in multi-site FBA studies. Future work examining protocol-related differences, as well as appropriate harmonisation strategies when pooling data across sites and scanners, will be valuable.

  • Open Access

    Automated detection of bottom-of-sulcus dysplasia on MRI-PET in patients with drug-resistant focal epilepsy

    by Emma Macdonald-Laurs, Aaron E.L. Warren, Remika Mito, Sila Genc, Bonnie Alexander, Sarah Barton, Joseph Yuan-Mou Yang, Peter Francis, Heath R. Pardoe, Graeme Jackson, et al.

    Background and Objectives: Bottom-of-sulcus dysplasia (BOSD) is a diagnostically challenging subtype of focal cortical dysplasia, 60% being missed on patients’ first MRI. Automated MRI-based detection methods have been developed for focal cortical dysplasia, but not BOSD specifically. Use of FDG-PET alongside MRI is not established in automated methods. We report the development and performance of an automated BOSD detector using combined MRI+PET data. Methods: The training set comprised 54 mostly operated patients with BOSD. The test sets comprised 17 subsequently diagnosed patients with BOSD from the same center, and 12 published patients from a different center. 81% patients across training and test sets had reportedly normal first MRIs and most BOSDs were 3 . In the training set, 12 features from T1-MRI, FLAIR-MRI and FDG-PET were evaluated using a novel “pseudo-control” normalization approach to determine which features best distinguished dysplastic from normal-appearing cortex. Using the Multi-centre Epilepsy Lesion Detection group’s machine-learning detection method with the addition of FDG-PET, neural network classifiers were then trained and tested on MRI+PET features, MRI-only and PET-only. The proportion of patients whose BOSD was overlapped by the top output cluster, and the top five output clusters, were assessed. Results: Cortical and subcortical hypometabolism on FDG-PET were superior in discriminating dysplastic from normal-appearing cortex compared to MRI features. When the BOSD detector was trained on MRI+PET features, 87% BOSDs were overlapped by one of the top five clusters (69% top cluster) in the training set, 76% in the prospective test set (71% top cluster) and 75% in the published test set (42% top cluster). Cluster overlap was similar when the detector was trained and tested on PET-only features but lower when trained and tested on MRI-only features. Conclusion: Detection of BOSD is possible using established MRI-based automated detection methods, supplemented with FDG-PET features and trained on a BOSD-specific cohort. In clinical practice, an MRI+PET BOSD detector could improve assessment and outcomes in seemingly MRI-negative patients being considered for epilepsy surgery.

  • Open Access

    Beyond the Resection: Surgical White Matter Disruption Structurally Alters Non-Resected Brain Anatomy

    by Philip Pruckner, Remika Mito, David Vaughan, Graeme Jackson, Florian Fischmeister, Karl Heinz-Nenning, Marc Berger, Ekaterina Pataraia, Christoph Baumgartner, Christian Dorfer, et al.

    Resective neurosurgery is a cornerstone treatment for many neurological conditions. Although traditionally viewed as localised procedure, increasing evidence from advanced magnetic resonance imaging (MRI) shows that also non-resected anatomy can degenerate following surgery. The relationship between local tissue removal and these postoperative changes remains thus far speculative. Here, we investigate the hypothesis that degenerative changes to surgically preserved grey and white matter are mediated by transneuronal degeneration , a deterioration of intact neuronal populations due to lost axonal input. Using a robust structural and diffusion MRI framework, we first identify widespread postoperative atrophy: pronounced cortical thickness decreases near the resection, and extensive white matter impairments across the ipsilateral hemisphere. Importantly, we then link these alterations to surgical white matter disruption, revealing a sequential network atrophy following neurosurgery. Beyond degenerative effects, we also demonstrate often reported structural network reorganisations as an artefact of image processing, indicating limited capacity for macroscale plasticity post-resection. Key Points: Resective neurosurgery can lead to postoperative atrophy of non-resected grey and white matter. Utilising a robust longitudinal neuroimaging framework, we evaluate these changes as consequences of transneuronal degeneration , demonstrating a sequential atrophy of brain anatomy following the loss of surgically disrupted white matter. The majority of severed connections projected to atrophic cortices near the resection, indicating them to be short association fibers. Consecutive white matter atrophy however affected extensive ipsilateral pathways, highlighting a cascading network effect of resective brain surgery. We did not find evidence to support often reported structural reorganisations of large-scale brain networks post-resection. Yet, we demonstrate that evidence typically interpreted as such can be replicated when using non-robust reconstruction methods.